Cancer Research

Published by: American Association for Cancer Research  

People

  1. Bosl
    Bosl
  2. Chaganti
    Chaganti
  3. Houldsworth El Naggar
    Houldsworth El Naggar
  4. Rosen
    Rosen
  5. Hudis
    Hudis
  6. Korkola
    Korkola
  7. Modi
    Modi
  8. Reuter
    Reuter
  9. Chandarlapaty
    Chandarlapaty
  10. King
    King

Groups

  1. Sloan Kettering Institute Faculty (32)
  2. Survivorship Research (32)
  3. Department of Medicine (21)
  4. Solid Tumor Oncology Division (21)
  5. GSK Faculty (18)
  6. Molecular Pharmacology and Chemistry Program Faculty (15)
  7. Breast Medicine Service (14)
  8. Cell Biology Program Faculty (13)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  10. Biostatistics Service (9)
Search Within
  1. "Survivorship Research"
  2. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (11)
Groups
  1. Sloan Kettering Institute Faculty (32)
  2. Survivorship Research (32)
  3. Department of Medicine (21)
  4. Solid Tumor Oncology Division (21)
  5. GSK Faculty (18)
  6. Molecular Pharmacology and Chemistry Program Faculty (15)

More Groups

People
  1. George Bosl (13)
  2. Raju Chaganti (13)
  3. Jane Houldsworth El Naggar (8)
  4. Neal Rosen (8)
  5. Clifford Hudis (6)
  6. James Korkola (6)

More People

Years
  1. 2021 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2015 (2)
  6. 2013 (3)

More Years

Publishers
  1. American Association for Cancer Research (32)

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Self-assembling and disassembling bispecific antibody platform for pretargeted radioimmunotherapy against GPA33 in a xenograft model of colorectal peritoneal carcinomatosis
    Meeting Abstract

    Chung, S.; Wang, M.; Veach, D.; Cheal, S.; Burnes Vargas, D.; Seo, S. H.; Punzalan, B.; Santich, B.; Guo, H. F.; Xu, H.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Meeting Abstract

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to cisplatin and poly (ADP-ribose) polymerase inhibition
    Meeting Abstract

    Cavallo, F.; Graziani, G.; Antinozzi, C.; Feldman, D. R.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.; Moynahan, M. E.; Jasin, M.; Barchi, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A comprehensive study to analyze tumor sensitivity to HSP90 inhibition therapy
    Meeting Abstract

    Riolo, M.; Modi, S.; Corben, A.; Hudis, C.; Alpaugh, M.; Chiosis, G.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Molecular predictors for type of recurrence following conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Chandarlapaty, S.; Giovanni, C.; Giri, D.; Heguy, A.; De Brot, M.; Olvera, N.; Muhsen, S.; Koslow, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research